CoChat

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer

Open access
Solinas, Cinzia, Garaud, Soizic, De Silva, Pushpamali, Boisson, Anaïs, Van den Eynden, Gert, de Wind, Alexandre, Risso, Paolo, Rodrigues Vitória, Joel, Richard, François, Migliori, Edoardo, Noël, Grégory, Duvillier, Hugues, Craciun, Ligia, Veys, Isabelle, Awada, Ahmad, Detours, Vincent, Larsimont, Denis, Piccart-Gebhart, Martine, Willard-Gallo, Karen · 2017 · Frontiers in Immunology
Cited by 106

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

There is an exponentially growing interest in targeting immune checkpoint molecules in breast cancer, particularly in the triple-negative subtype where unmet treatment needs remain. This study was designed to analyze the expression, localization and prognostic role of PD-1, PD-L1, PD-L2, CTLA-4, LAG3 and TIM3 in primary breast cancer. Gene expression analysis using the METABRIC microarray dataset found that all six immune checkpoint molecules are highly expressed in basal-like and HER2-enriched compared to the other breast cancer molecular subtypes. Flow cytometric analysis of fresh tissue homogenates from untreated primary tumors show that PD-1 is principally expressed on CD4+ or CD8+ T cells and CTLA-4 on CD4+ T cells. The global proportion of PD-L1+, PD-L2+, LAG3+ and TIM3+ tumor infiltrating lymphocytes was low and detectable in only a small number of tumors. Immunohistochemically staining fixed tissues from the same tumors was employed to score tumor infiltrating lymphocytes and tertiary lymphoid structures. PD-L1+, PD-L2+, LAG3+ and TIM3+ cells were detected in some tertiary lymphoid structures in a pattern that resembles secondary lymphoid organs. This observation suggests that tertiary lymphoid structures are important sites of immune activation and regulation, particularly in tumors with extensive baseline immune infiltration. Significantly improved overall survival was correlated with PD-1 expression in the HER2-enriched and PD-L1 or CTLA-4 expression in basal-like breast cancer. PD-1 and CTLA-4 proteins were most frequently detected on tumor infiltrating lymphocytes, which supports the correlations observed between their gene expression and improved long term outcome in basal-like and HER2-enriched breast cancer. PD-L1 expression by tumor or immune cells is uncommon in breast cancer. Overall, the data presented here distinguish PD-1 as a marker of T cell activity in both the T and B cell areas of breast cancer associated tertiary lymphoid structures. We found that immune checkpoint molecule expression parallels the extent of tumor infiltrating lymphocytes and tertiary lymphoid structures, although there is a noteworthy amount of heterogeneity between tumors even within the same molecular subtype. These data indicate that assessing the levels of immune checkpoint molecule expression in an individual patient has important implications for the success of therapeutically targeting them in breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2017.01412

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 106

Metadata

Authors
Solinas, C., Garaud, S., De Silva, P., Boisson, A., Van den Eynden, G., de Wind, A., Risso, P., Rodrigues Vitória, J., Richard, F., Migliori, E., Noël, G., Duvillier, H., Craciun, L., Veys, I., Awada, A., Detours, V., Larsimont, D., Piccart-Gebhart, M., & Willard-Gallo, K.
Venue
Frontiers in Immunology
Published
2017-10-30
Volume
8
Pages
1412-1412
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2765492972
Cited by
106
References
11
FWCI
4.20
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer. https://app.cochat.ai/papers/10.3389/fimmu.2017.01412
The paper
Solinas, C., Garaud, S., De Silva, P., Boisson, A., Van den Eynden, G., de Wind, A., Risso, P., Rodrigues Vitória, J., Richard, F., Migliori, E., Noël, G., Duvillier, H., Craciun, L., Veys, I., Awada, A., Detours, V., Larsimont, D., Piccart-Gebhart, M., & Willard-Gallo, K. (2017). Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.01412

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.